Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lymphocytes, Tumor-Infiltrating"" wg kryterium: Temat


Tytuł:
Exploration of the relationship between tumor-infiltrating lymphocyte score and histological grade in breast cancer.
Autorzy:
Kang D; Department of Pathology, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Wang C; Breast Surgery Ward, Department of General Surgery, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Han Z; Breast Surgery Ward, Department of General Surgery, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Zheng L; Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, College of Photonic and Electronic Engineering, Fujian Normal University, 350007, Fuzhou, P. R. China.
Guo W; Breast Surgery Ward, Department of General Surgery, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Fu F; Breast Surgery Ward, Department of General Surgery, Fujian Medical University Union Hospital, 350001, Fuzhou, P. R. China.
Qiu L; College of Physics and Electronic Information Engineering, Minjiang University, 350108, Fuzhou, P. R. China.
Han X; Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, College of Photonic and Electronic Engineering, Fujian Normal University, 350007, Fuzhou, P. R. China.
He J; School of Science, Jimei University, 361021, Xiamen, P. R. China. .
Li L; Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, College of Photonic and Electronic Engineering, Fujian Normal University, 350007, Fuzhou, P. R. China. .
Chen J; Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, College of Photonic and Electronic Engineering, Fujian Normal University, 350007, Fuzhou, P. R. China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 318. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Humans ; Female ; Lymphocytes, Tumor-Infiltrating/pathology ; Prognosis
Czasopismo naukowe
Tytuł:
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy.
Autorzy:
Arqueros C; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Gallardo A; Department of Pathology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Morphological Sciences, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Vidal S; Inflammatory Diseases, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Osuna-Gómez R; Inflammatory Diseases, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Tibau A; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Lidia Bell O; Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Ramón Y Cajal T; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Lerma E; Department of Pathology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Morphological Sciences, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Lobato-Delgado B; Unitat de Genòmica de Malalties Complexes, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Salazar J; Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.
Barnadas A; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.; Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Translational Medical Oncology Laboratory, Institut d'Investigació Biomèdica Sant Pau (IIB-Sant Pau), Institut de Recerca Sant Pau-CERCA Center, 08041 Barcelona, Spain.; Centro de Investigación Biomedica en Red Cancer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; Neoadjuvant Therapy/adverse effects ; Clinical Relevance ; Retrospective Studies ; Biomarkers, Tumor/analysis ; Lymphocytes, Tumor-Infiltrating ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer: A comparison study with HER2-zero and HER2-positive disease.
Autorzy:
Lu Y; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tong Y; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fei X; Department of Pathology, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen X; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen K; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (15), pp. 16264-16278. Date of Electronic Publication: 2023 Jun 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Breast Neoplasms*/diagnosis
Biomarkers, Tumor ; Disease-Free Survival ; In Situ Hybridization, Fluorescence ; Prognosis ; Receptor, ErbB-2 ; Retrospective Studies
Czasopismo naukowe
Tytuł:
The expression profiles of signature genes from CD103 tumour-infiltrating lymphocyte subsets predict breast cancer survival.
Autorzy:
Xia ZA; Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.; National Clinical Research Center for Geriatric Disorders, XiangyaHospital, Central South University, Changsha, 410008, China.
Lu C; Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410078, China.
Pan C; School of Clinical Medicine, Hunan University of Traditional Chinese Medicine, Changsha, 410208, China.
Li J; Department of Emergency, Xiangya Hospital, Central South University, Changsha, 410008, China.
Li J; Department of Nuclear Medicine, Peking University Shenzhen Hospital, Guangdong, 518036, China.
Mao Y; Department of Radiology, Xiangya Hospital, Central South University, Changsha, 410078, China.
Sun L; National Clinical Research Center for Geriatric Disorders, XiangyaHospital, Central South University, Changsha, 410008, China. .; Department of Oncology, Xiangya Cancer Center, XiangyaHospital, Central South University, Changsha, 410008, China. .; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China. .; Hunan International Science and Technology Collaboration Base of Precision Medicine for Cancer, Changsha, 410008, China. .; Center for Molecular Imaging of Central, South University, Xiangya Hospital, Changsha, 410008, China. .
He J; National Clinical Research Center for Geriatric Disorders, XiangyaHospital, Central South University, Changsha, 410008, China. .; Department of Oncology, Xiangya Cancer Center, XiangyaHospital, Central South University, Changsha, 410008, China. .; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Jul 24; Vol. 21 (1), pp. 268. Date of Electronic Publication: 2023 Jul 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*/immunology
Breast Neoplasms*/drug therapy
Breast Neoplasms*/immunology
Humans ; Prognosis ; Antineoplastic Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer.
Autorzy:
Reznitsky FM; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.; Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark.
Jensen JD; Department of Oncology, Odense University Hospital, Funen, Denmark.
Knoop A; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Jensen MB; Danish Breast Cancer Group, Copenhagen University Hospital, Copenhagen, Denmark.
Laenkholm AV; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1913-1920. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Humans ; Female ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Prognosis ; Class I Phosphatidylinositol 3-Kinases/genetics ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer.
Autorzy:
Landén AH; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Chin K; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Kovács A; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Holmberg E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Molnar E; Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Stenmark Tullberg A; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Wärnberg F; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1862-1872. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/drug therapy
Breast Neoplasms*/etiology
Carcinoma*/pathology
Humans ; Female ; Lymphocytes, Tumor-Infiltrating/pathology ; Breast Density ; Neoadjuvant Therapy/methods ; Prognosis
Czasopismo naukowe
Tytuł:
Unveiling the Immune Microenvironment's Role in Breast Cancer: A Glimpse into Promising Frontiers.
Autorzy:
Kotsifaki A; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Alevizopoulos N; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Dimopoulou V; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Armakolas A; Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 18; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Breast Neoplasms*/pathology
Humans ; Female ; Lymphocytes, Tumor-Infiltrating ; Combined Modality Therapy ; Cytokines ; Tumor Microenvironment ; Immunotherapy
Czasopismo naukowe
Tytuł:
Significance of tumor-infiltrating lymphocytes in tumor regression in breast cancer: A study in a tertiary care cancer center in South India.
Autorzy:
Mishra B; Department of Lab Medicine, Basavatarakam Indo American Cancer Hospital, Hyderabad, India.
Kodandapani S; Department of Lab Medicine, Basavatarakam Indo American Cancer Hospital, Hyderabad, India.
Challa S; Department of Lab Medicine, Basavatarakam Indo American Cancer Hospital, Hyderabad, India.
Dash S; Department of Oncopathology, Acharya Harihar Post-Graduate Institute of Cancer, Cuttack, Odisha, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Oct 01; Vol. 19 (7), pp. 1837-1843. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/therapy
Carcinoma, Lobular*
Female ; Humans ; Lymphocytes, Tumor-Infiltrating ; Tertiary Healthcare ; India/epidemiology
Czasopismo naukowe
Tytuł:
The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy.
Autorzy:
Oner G; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.; Department of General Surgery, Kocaeli University, Kocaeli, Turkey.
Broeckx G; Department of Histopathology, Antwerp University Hospital, Edegem, Belgium.
Van Berckelaer C; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.
Zwaenepoel K; Department of Histopathology, Antwerp University Hospital, Edegem, Belgium.
Altintas S; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.
Canturk Z; Department of General Surgery, Kocaeli University, Kocaeli, Turkey.
Tjalma W; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.
Berneman Z; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.; Department of Hematology, Antwerp University Hospital, Edegem, Belgium.
Peeters M; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.
Pauwels P; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.; Department of Histopathology, Antwerp University Hospital, Edegem, Belgium.
van Dam PA; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 17901-17913. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Humans ; Middle Aged ; Female ; Neoadjuvant Therapy/methods ; Aromatase Inhibitors/therapeutic use ; Ki-67 Antigen ; Phosphatidylinositol 3-Kinases ; Lymphocytes, Tumor-Infiltrating ; Tumor Microenvironment ; Prognosis ; Biomarkers, Tumor
Czasopismo naukowe
Tytuł:
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype.
Autorzy:
Orrù S; Department of Pathology, 'A. Businco' Oncologic Hospital, ARNA S Brotzu, Via Edward Jenner 1, 09121, Cagliari, Italy.
Pascariello E; Department of Pathology, 'A. Businco' Oncologic Hospital, ARNA S Brotzu, Via Edward Jenner 1, 09121, Cagliari, Italy.
Pes B; Dipartimento di Matematica e Informatica, University of Cagliari, Palazzo delle Scienze, Via Ospedale 72, 09124, Cagliari, Italy.
Rallo V; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche, CNR, Cittadella Universitaria di Cagliari, 09042, Monserrato, Cagliari, Italy.
Barbara R; Department of Radiotherapy, 'A. Businco' Oncologic Hospital, ARNAS Brotzu, Via Edward Jenner 1, 09121, Cagliari, Italy.
Muntoni M; Department of Pathology, 'A. Businco' Oncologic Hospital, ARNA S Brotzu, Via Edward Jenner 1, 09121, Cagliari, Italy.
Notari F; Department of Pathology, 'A. Businco' Oncologic Hospital, ARNA S Brotzu, Via Edward Jenner 1, 09121, Cagliari, Italy.
Fancello G; Breast Surgery Department, 'A. Businco' Oncologic Hospital, ARNAS Brotzu, Via Edward Jenner 1, 09121, Cagliari, Italy.
Mocci C; Department of Pathology, 'A. Businco' Oncologic Hospital, ARNA S Brotzu, Via Edward Jenner 1, 09121, Cagliari, Italy.
Muroni MR; Department of Medicine, Surgery and Pharmacy, University of Sassari, Via P. Manzella 4, 07100, Sassari, Italy.
Cossu-Rocca P; Department of Medicine, Surgery and Pharmacy, University of Sassari, Via P. Manzella 4, 07100, Sassari, Italy.; Department of Diagnostic Services, 'Giovanni Paolo II' Hospital, ASSL Olbia-ATS Sardegna, Via Bazzoni-Sircana, 07026, Olbia, Italy.
Angius A; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche, CNR, Cittadella Universitaria di Cagliari, 09042, Monserrato, Cagliari, Italy. .
De Miglio MR; Department of Medicine, Surgery and Pharmacy, University of Sassari, Via P. Manzella 4, 07100, Sassari, Italy. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 08; Vol. 13 (1), pp. 12869. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Humans ; Female ; Neoadjuvant Therapy ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Trastuzumab/therapeutic use ; Lymphocytes, Tumor-Infiltrating ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Treatment Outcome ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy.
Autorzy:
Wang Q; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Sun K; State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, China.; Yunnan Key Laboratory of Primate Biomedical Research, Kunming, China.
Liu R; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Song Y; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Lv Y; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Bi P; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Yang F; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Li S; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhao J; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Li X; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Chen D; Department of Ultrasound, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Mei J; Department of Cardiothoracic Surgery, Baoshan People's Hospital, Baoshan, China.
Yang R; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China.; Department of Immunology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
Chen K; State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, China.; Yunnan Key Laboratory of Primate Biomedical Research, Kunming, China.
Liu D; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Tang S; Department of Breast Surgery, Caner Hospital of Yunnan Province, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Aug; Vol. 13 (8), pp. e1346.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/diagnosis
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Tertiary Lymphoid Structures*/genetics
Tertiary Lymphoid Structures*/metabolism
Humans ; Female ; Transcriptome/genetics ; Neoadjuvant Therapy ; Lymphocytes, Tumor-Infiltrating ; Prognosis
Czasopismo naukowe
Tytuł:
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
Autorzy:
Mollavelioglu B; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Cetin Aktas E; Department of Immunology, Istanbul University, Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.
Cabioglu N; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Abbasov A; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Onder S; Department of Pathology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.
Emiroglu S; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Tükenmez M; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Muslumanoglu M; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Igci A; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey.
Deniz G; Department of Immunology, Istanbul University, Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.
Ozmen V; Istanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul, Turkey. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2022 Oct 21; Vol. 20 (1), pp. 349. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Breast Neoplasms*/pathology
Humans ; Female ; CTLA-4 Antigen ; Hepatitis A Virus Cellular Receptor 2/metabolism ; Programmed Cell Death 1 Receptor ; Ki-67 Antigen/metabolism ; Receptors, Immunologic/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer.
Autorzy:
Delmonico L; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-170, Brazil.
Bines J; National Cancer Institute (INCA), Rio de Janeiro 20560-121, Brazil.
Nascimento CMD; Pathology Division, National Cancer Institute (INCA), Rio de Janeiro 20220-400, Brazil.
Fernandes PV; Pathology Division, National Cancer Institute (INCA), Rio de Janeiro 20220-400, Brazil.
Barbosa IS; Circulating Biomarkers Laboratory, Faculty of Medical Sciences, Department of General Pathology, Rio de Janeiro State University, Rio de Janeiro 22550-170, Brazil.
Ribeiro GB; Circulating Biomarkers Laboratory, Faculty of Medical Sciences, Department of General Pathology, Rio de Janeiro State University, Rio de Janeiro 22550-170, Brazil.
de Paula BHR; National Cancer Institute (INCA), Rio de Janeiro 20560-121, Brazil.
Silvestre RT; Circulating Biomarkers Laboratory, Faculty of Medical Sciences, Department of General Pathology, Rio de Janeiro State University, Rio de Janeiro 22550-170, Brazil.
Ornellas MHF; Circulating Biomarkers Laboratory, Faculty of Medical Sciences, Department of General Pathology, Rio de Janeiro State University, Rio de Janeiro 22550-170, Brazil.
Alves G; Circulating Biomarkers Laboratory, Faculty of Medical Sciences, Department of General Pathology, Rio de Janeiro State University, Rio de Janeiro 22550-170, Brazil.
Lage C; Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-170, Brazil.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Apr 07; Vol. 30 (4), pp. 4094-4109. Date of Electronic Publication: 2023 Apr 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Female ; Humans ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Neoadjuvant Therapy/methods ; Prognosis ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism
Czasopismo naukowe
Tytuł:
Ultrasound features combined with tumor-infiltrating lymphocytes for prediction of pathological response to neoadjuvant chemotherapy in breast cancer.
Autorzy:
Jia Y; Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, Gansu, China. .
Zhou X; Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, Gansu, China. .
Zhu Y; Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, Gansu, China. .
Song X; Pathology department, Lanzhou University Second Hospital. .
Duan Y; Ultrasound Medical Center, Lanzhou University Second Hospital. .
Chen K; Ultrasound Medical Center, Lanzhou University Second Hospital. .
Nie F; Ultrasound Medical Center, Lanzhou University Second Hospital, China. ery_.
Pokaż więcej
Źródło:
Medical ultrasonography [Med Ultrason] 2023 Jun 26; Vol. 25 (2), pp. 131-138.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Humans ; Female ; Treatment Outcome ; Neoadjuvant Therapy ; Lymphocytes, Tumor-Infiltrating/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Effects of tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer.
Autorzy:
Qian XL; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Xia XQ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Li YQ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Jia YM; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Sun YY; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Song YM; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Xue HQ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Hao YF; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Wang J; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Wang XZ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Liu CY; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China.
Zhang XM; Department of Pathology, Cooper Medical School of Rowan University, Camden, NJ, USA.
Zhang LN; The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, Tianjin, 300060, China.
Guo XJ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 07; Vol. 13 (1), pp. 9256. Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; Lymphocytes, Tumor-Infiltrating ; Neoadjuvant Therapy ; Prognosis ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Receptor, ErbB-2
Czasopismo naukowe
Tytuł:
Characterization of immune checkpoints expression and lymphocyte densities of iranian breast cancer patients; the co-expression status and clinicopathological associates.
Autorzy:
Pournabee M; Breast Disease Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Keshavarz-Fathi M; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.; Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Esmaeili P; Cancer Institute, Pathology Department, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran, Iran.
Mahdavi Sharif P; Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Nili F; Cancer Institute, Pathology Department, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran, Iran.
Jahanbin B; Cancer Institute, Pathology Department, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jun 01; Vol. 23 (1), pp. 495. Date of Electronic Publication: 2023 Jun 01.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; B7-H1 Antigen/metabolism ; Iran/epidemiology ; Retrospective Studies ; Programmed Cell Death 1 Receptor/metabolism ; Prognosis ; Biomarkers/metabolism ; Lymphocytes, Tumor-Infiltrating ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Tytuł:
TCGA RNA-Seq and Tumor-Infiltrating Lymphocyte Imaging Data Reveal Cold Tumor Signatures of Invasive Ductal Carcinomas and Estrogen Receptor-Positive Human Breast Tumors.
Autorzy:
Bou-Dargham MJ; Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306, USA.
Sha L; Department of Statistics, Florida State University, Tallahassee, FL 32306, USA.
Sarker DB; Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306, USA.
Krakora-Compagno MZ; Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306, USA.
Chen Z; Abbisko Therapeutics, Shanghai 200100, China.
Zhang J; Department of Statistics, Florida State University, Tallahassee, FL 32306, USA.
Sang QA; Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306, USA.; Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 27; Vol. 24 (11). Date of Electronic Publication: 2023 May 27.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/metabolism
Carcinoma, Lobular*/metabolism
Triple Negative Breast Neoplasms*/pathology
Carcinoma, Ductal*/metabolism
Humans ; Female ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Lymphocytes, Tumor-Infiltrating ; RNA-Seq
Czasopismo naukowe
Tytuł:
The ratio of intratumour to stromal infiltrating lymphocytes better predicts prognosis in breast cancer.
Autorzy:
Zhang B; Department of Chemical and Biomolecular Engineering, Rice University, Houston, Texas, USA.
Wang X; Quantitative and Computational Biology Program, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, Texas, USA.
Cheng C; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 May; Vol. 13 (5), pp. e1265.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Breast Neoplasms*/diagnosis
Breast Neoplasms*/pathology
Humans ; Female ; Prognosis ; Lymphocytes ; Lymphocytes, Tumor-Infiltrating
Raport
Tytuł:
Expression of programmed death ligand-1 (PD-L1) and tumor infiltrating lymphocytes (TILs) in breast carcinoma and their clinical significance.
Autorzy:
Mondal SK; Department of Pathology, All India Institute of Medical Science, Kalyani, West Bengal, India.
Bhattacharya S; Department of Pathology, Bankura Sammilani Medical College, Bankura, West Bengal, India.
Sarkar AP; Community Medicine, Bankura Sammilani Medical College, Bankura, West Bengal, India.
Saha R; Department of Pathology, All India Institute of Medical Science, Kalyani, West Bengal, India.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr; Vol. 19 (Supplement), pp. S81-S86.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Carcinoma*/pathology
Humans ; Female ; Prognosis ; B7-H1 Antigen/metabolism ; Lymphocytes, Tumor-Infiltrating ; Clinical Relevance ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Tytuł:
Inter-observer agreement of tumor infiltrating lymphocytes in primary HER2-positive breast cancer and correlation between tissue microarray and full tumor-sections.
Autorzy:
Reznitsky FM; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.; Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark.
Jensen JD; Department of Oncology, Odense University Hospital, Odense, Denmark.
Knoop A; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Laenkholm AV; Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
Pokaż więcej
Źródło:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2022 Sep; Vol. 130 (9), pp. 545-550. Date of Electronic Publication: 2022 Jun 26.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnosis
Breast Neoplasms*/pathology
Lymphocytes, Tumor-Infiltrating*/pathology
Biomarkers, Tumor/analysis ; Female ; Humans ; Observer Variation ; Pathologists ; Prognosis ; Receptor, ErbB-2/analysis ; Tumor Microenvironment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies